ArticleJournal of the National Cancer Institute2011

Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.

Genevieve M Monsees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.